Metraipolis › archive › dc_5eb270b6e673

Comparative real-world outcomes of tirzepatide vs semaglutide in patients with obesity and type2 diabetes: A retrospective propensity-matched cohort study — Europe PMC PMID:42376874

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42376874
DOI
10.1177/14791641261465360
License (as archived)
solo-consultazione
Archived
2026-11-02T20:19:01.102Z
SHA-256 of the archived text
fdcf5542a60d429b9ede2923c29644a169b6cbd30a418cf5524dc7f9f3d1fc87
Stable URL of this page
https://metraipolis.com/documento/dc_5eb270b6e673

How to cite

Comparative real-world outcomes of tirzepatide vs semaglutide in patients with obesity and type2 diabetes: A retrospective propensity-matched cohort study — Europe PMC PMID:42376874 — Europe PMC (en), https://europepmc.org/article/MED/42376874 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5eb270b6e673 (Metraipolis archive dc_5eb270b6e673, sha256 fdcf5542a60d429b9ede2923c29644a169b6cbd30a418cf5524dc7f9f3d1fc87)
BibTeX
@misc{dc5eb270b6e673,
  title = {Comparative real-world outcomes of tirzepatide vs semaglutide in patients with obesity and type2 diabetes: A retrospective propensity-matched cohort study — Europe PMC PMID:42376874},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42376874},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5eb270b6e673; sha256 fdcf5542a60d429b9ede2923c29644a169b6cbd30a418cf5524dc7f9f3d1fc87},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42376874. Agents can read the archived copy with the MCP tool read_document.